RECENT NEWS

Owen Mumford has signed an exclusive agreement with Stevanato Group for the Aidaptus auto-injector. The agreement makes Stevanato Group an exclusive manufacturing partner for the Owen Mumford designed auto-injector, offering a full set of capabilities to its pharmaceutical customers.

The Royal College of Nursing is calling on health and care staff to think ‘is this necessary?’ every time they reach for the examination gloves and to ‘make one change’ during Glove Awareness Week (2-9 May).

NHS Confederation, NHS England and NHS Improvement have joined forces to bring together two long-standing conferences and create a new event: NHS ConfedExpo. NHS ConfedExpo will run for two days on 15 and 16 June 2022 at ACC Liverpool.

The NHS Confederation has teamed up with the Institute for Public Policy Research (IPPR) to explore how the NHS, public services and local government can work together to build health across a whole health economy.

Three videos highlighting the importance of patients with diabetes being able to administer their own insulin while in hospital are being shared by the Getting It Right First Time (GIRFT) programme, to co-incide with Insulin Safety Week 2022.

British surgical instrument manufacturer, Surgical Holdings, has announced the launch of a new company-wide green initiative to reduce both their and the NHS’s carbon footprint.

UK HealthTech companies wanting to showcase their pioneering products and services at this year’s MEDICA trade fair have until 30 May 2022 to book their place on the ABHI UK Pavilion.

A life-saving test that allows doctors to spot a rare form of eye cancer in babies in the womb is being rolled out by NHS in England.

Nuffield Health, one of the UK’s largest healthcare charities, has announced the opening of the City of London’s first independent hospital, located within the grounds of Barts Health NHS Trust’s St Bartholomew’s Hospital site, a leading specialist heart and cancer centre in Europe.

Organisations representing hundreds of thousands of pregnant employees some of which are healthcare workers have expressed concern at the withdrawal without any warning of COVID-19 guidance by the Department of Health and Social Care (DHSC) for employers on how to protect pregnant employees.

Lifelong excess weight almost doubles a woman’s risk of developing womb cancer, according to a Cancer Research UK-funded study published in BMC Medicine.

The latest Health and Care Bill has now received Royal Assent, meaning it will now become law.

New guidelines aiming to support clinicians in the diagnosis of fibromyalgia syndrome (FMS) have been published by the Royal College of Physicians (RCP).

Dartford and Gravesham NHS Trust has entered the next stages in its digitisation journey with the procurement of two technologies that will alleviate pressure on emergency department staff, theatres and recovery.

The Government has tabled a landmark amendment to the Health and Care Bill aiming to eradicate the use of goods and services in the NHS that are tainted by slavery and human trafficking.

The world’s first Scalp Cooling Summit will unite global oncology and research thought leaders to discuss current practice and how to advance the future of scalp cooling and side effect management in cancer care.

The UK Health Security Agency (UKHSA), Public Health Scotland, Public Health Wales and the Public Health Agency are continuing to investigate a rise in cases of sudden onset hepatitis (liver inflammation) in children aged 10 and under since January 2022, where the usual viruses that cause infectious hepatitis (hepatitis A to E) have not been detected.

Two new antimicrobial drugs, cefiderocol and ceftazidime-avibactam, are close to becoming the first to be made available as part of the UK’s innovative subscription-style payment model, after NICE published draft guidance estimating their value to the NHS.

Analysis by the Health Foundation has revealed that life expectancy for women living in the poorest 10% of areas in England is lower than overall life expectancy in any OECD country, except for Mexico.

Dr. Thomas Waite will support Chief Medical Officer (CMO) Professor Chris Whitty as the deputy CMO (DCMO) leading on health protection, replacing Professor Jonathan Van-Tam who stepped down on 31 March 2022. His role will cover emergency response and preparedness, infectious diseases, vaccines and therapeutics.